| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |